Why the study?
The optimal timing of intervention for asymptomatic severe aortic stenosis remains controversial, balancing the risks of early intervention against watchful observation.
Does early surgical aortic valve replacement reduce operative or cardiovascular death in asymptomatic patients with severe aortic stenosis compared to watchful observation?
Does early surgical aortic valve replacement reduce operative or cardiovascular death in asymptomatic patients with severe aortic stenosis compared to watchful observation?
Early surgical aortic valve replacement is a reasonable and beneficial strategy for asymptomatic patients with very severe aortic stenosis and low surgical risk, significantly reducing cardiovascular mortality compared to watchful waiting.
Answers are grounded in this paper and cite their sources.
May support early surgery in asymptomatic very severe AS; leaves open confirmation in broader populations.
The decision to perform an intervention for asymptomatic severe aortic stenosis (AS) requires careful weighing of the risks of early intervention against those of watchful observation, and the optimal timing of intervention remains controversial. With improvements in surgical and postoperative care, long-term survival after surgical aortic valve (AV) replacement (AVR) is excellent in low-risk patients, and the emergence of transcatheter AVR may change the thresholds for early preemptive intervention, although a durability issue has to be resolved. A watchful observation strategy also has a risk of sudden death, irreversible myocardial damage, and increase in operative risk while waiting for symptoms to develop. We have been waiting for a prospective randomized trial to solve the intense debate between early AVR and watchful observation, and the RECOVERY (Randomized Comparison of Early Surgery versus Conventional Treatment in Very Severe Aortic Stenosis) trial provides the evidence to support early AVR for asymptomatic severe AS. Risk assessment with severity of AS and staging classification may help to facilitate the identification of patients who may benefit from early intervention. Based on the results of the RECOVERY trial, early surgical AVR is reasonable for asymptomatic patients with very severe AS (aortic jet velocity ≥4.5 m/s) and low surgical risk. Further evidence is required to extend the indications of surgical AVR and to consider transcatheter AVR in asymptomatic patients with severe AS.
No takes yet. Share an insight, caveat, or question.
A 2021 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: